Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes (NCT05124808)
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes Mellitus: A Multicenter Randomized Trial
🩺 Plain-English Summary (8th-Grade Level)
This is a multicenter randomized clinical trial of 828 overweight and obese individuals with gestational diabetes designed to compare standard to intensive glycemic targets.
Who can join: Review the eligibility criteria below.
Location: University of Alabama at Birmingham — Birmingham, Alabama
Age range: 18 Years to 45 Years
🧪 Interventions in This Study
- Intensive glycemic targets (OTHER)
- Standard glycemic targets (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (5 Sites)
- University of Alabama at Birmingham — Birmingham, Alabama
- Indiana University — Indianapolis, Indiana
- University of Oklahoma — Norman, Oklahoma
- University of Pittsburgh — Pittsburgh, Pennsylvania
- Women and Infants Hospital of Rhode Island — Providence, Rhode Island
📞 Contact the Study Coordinator
Phone: (317) 944-7069
Email: seoswalt@iu.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Gestational Diabetes
- Preventing Obstetric Complications With Dietary Intervention — Milwaukee, Wisconsin
- Healthy Eating in Women at Risk of Gestational Diabetes — Québec, Quebec
- Role of Adipokines in Glucose Regulation During Pregnancy and in Fetal Development — Sherbrooke, Quebec
- Predicting Dysglycemia in Individuals With Gestational Diabetes Immediately Postpartum Using Continuous Glucose Monitoring — Calgary, Alberta
- Role of NADPH Oxidase in Microvascular Dysfunction Following GDM — Iowa City, Iowa
- Gestational Diabetes and Pharmacotherapy (GAP) — Milwaukee, Wisconsin
Explore by condition: All Gestational Diabetes clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.